Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Johnson & Johnson

Johnson & Johnson

ADVERTISEMENT
News and Trends

Yumanity selling neurology assets and merging with Kineta

U.S. biopharma company Yumanity Therapeutics, Inc. is selling off its lead clinical-stage neurodegenerative product candidate…

By Jim Cornall
07/06/2022 - 3 minutes
News and Trends

As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues

Johnson & Johnson became the latest company to have a failed vaccine trial against HIV…

By Helen Albert
08/09/2021 - 5 minutes
News and Trends

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…

By Jonathan Smith
27/04/2021 - 6 minutes
Sponsored

This Incubator Knows How to Get Biotechs Started

When it comes to drug discovery and development, nowadays a lot of the work is…

By External Contributor
10/12/2018 - 6 minutes
Sponsored

Check Out Europe’s Hottest Pitching Event for Startups!

Last year Berlin, this year Copenhagen - No matter where in Europe, this is the…

By External Contributor
05/09/2018 - 5 minutes
Sponsored

The Startup Slam at BIO-Europe 2017! Choosing the Winner was Hard!

What would a large event like BIO-Europe be without startups? They’re not only the life…

By External Contributor
13/12/2017 - 4 minutes
News and Trends

UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech

The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and…

By Melanie De Almeida
15/06/2017 - 3 minutes
Best in Biotech

Which European Blockbusters Topped the Charts in 2016?

Blockbuster drugs are raking in billions each year in sales. Let's have a look at the top…

By Melanie De Almeida
08/03/2017 - 4 minutes
News and Trends

Actelion’s key Drug linked to Deaths, prompting EMA Investigation

Johnson & Johnson is certainly counting on its recent acquisition of the European biotech success Actelion…

By Melanie De Almeida
15/02/2017 - 3 minutes
News and Trends

Europe’s Largest Biotech Actelion Seals the Deal with J&J for €28B

Actelion will be acquired by J&J for a whopping €27.9B, and its early R&D pipeline…

By Evelyn Warner
26/01/2017 - 2 minutes
News and Trends

UPDATE: J&J and Actelion settle on a price, R&D assets will be spun out

UPDATE (12/01/2017): J&J and Actelion have reportedly settled on a price: $260 (€245) per share,…

By Clara Rodríguez Fernández
13/01/2017 - 4 minutes
News and Trends

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…

By Clara Rodríguez Fernández
26/12/2016 - 5 minutes
  • 1
  • 2
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast